The practice of evidence-based medicine （EBM） in recent years has spurred the increased study of the peri-operative period （POP） and has won acclaim. At present, surgeons fully recognize the importance of the POP ...The practice of evidence-based medicine （EBM） in recent years has spurred the increased study of the peri-operative period （POP） and has won acclaim. At present, surgeons fully recognize the importance of the POP and are enthusiastically immersing themselves actively into itsresearch.展开更多
Hyperlipidemia （HLP） is the No.1 risk factor for patients with atherosclerosis （AS） and is directly related to the occurrence of coronary artery disease （CAD） and cerebrovascular disease. Therefore, prevention a...Hyperlipidemia （HLP） is the No.1 risk factor for patients with atherosclerosis （AS） and is directly related to the occurrence of coronary artery disease （CAD） and cerebrovascular disease. Therefore, prevention and treatment of AS is of great importance and of practical significance in controlling the incidence and mortality of CAD. With its peculiar syndrome-dependent therapy, traditional Chinese medicine （TCM） has accumulated abundant practical experiences in this field and good clinical effects have been achieved. Chinese herbal medicine, with its particularly unique advantages and high potentials yet to be tapped, displays its huge strength in HLP prevention and treatment. The progress of studies concerning prevention and treatment of HLP by Chinese herbal medicines, in the form of monomers or compound recipes, is reviewed in this paper.展开更多
文摘The practice of evidence-based medicine （EBM） in recent years has spurred the increased study of the peri-operative period （POP） and has won acclaim. At present, surgeons fully recognize the importance of the POP and are enthusiastically immersing themselves actively into itsresearch.
基金Supported by the Natural Science Foundation of Zhejiang Province(No. Y204269)Chinese Medicine Foundation of Zhejiang Province(No.2005C004)
文摘Hyperlipidemia （HLP） is the No.1 risk factor for patients with atherosclerosis （AS） and is directly related to the occurrence of coronary artery disease （CAD） and cerebrovascular disease. Therefore, prevention and treatment of AS is of great importance and of practical significance in controlling the incidence and mortality of CAD. With its peculiar syndrome-dependent therapy, traditional Chinese medicine （TCM） has accumulated abundant practical experiences in this field and good clinical effects have been achieved. Chinese herbal medicine, with its particularly unique advantages and high potentials yet to be tapped, displays its huge strength in HLP prevention and treatment. The progress of studies concerning prevention and treatment of HLP by Chinese herbal medicines, in the form of monomers or compound recipes, is reviewed in this paper.
